Neuroimmunology of depression
- PMID: 34099111
- PMCID: PMC8877598
- DOI: 10.1016/bs.apha.2021.03.004
Neuroimmunology of depression
Abstract
Depression is one of the leading causes of disability worldwide and a major contributor to the global burden of disease, yet the cellular and molecular etiology of depression remain largely unknown. Major Depressive Disorder (MDD) is associated with a variety of chronic physical inflammatory and autoimmune disorders, and mood disorders may act synergistically with other medical disorders to worsen patient outcomes. Here, we outline the neuroimmune complement, explore the evidence for altered immune system function in MDD, and present some of the potential mechanisms by which immune cells and molecules may drive the onset and course of MDD. These include pro-inflammatory signaling, alterations in the hypothalamic-pituitary-adrenal axis, dysregulation of the serotonergic and noradrenergic neurotransmitter systems, neuroinflammation, and meningeal immune dysfunction. Finally, we discuss the interactions between current antidepressants and the immune system and propose the possibility of immunomodulatory drugs as potential novel antidepressant treatments.
Keywords: Antidepressants; Brain; Depression; HPA axis; Meninges; Neuroimmunology.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest statement The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.J Psychopharmacol. 2017 Sep;31(9):1149-1165. doi: 10.1177/0269881117711708. Epub 2017 Jun 27. J Psychopharmacol. 2017. PMID: 28653857 Free PMC article. Review.
-
The molecular mechanism of polysaccharides in combating major depressive disorder: A comprehensive review.Int J Biol Macromol. 2024 Feb;259(Pt 2):129067. doi: 10.1016/j.ijbiomac.2023.129067. Epub 2023 Dec 30. Int J Biol Macromol. 2024. PMID: 38163510 Review.
-
Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.J Psychiatry Neurosci. 2004 May;29(3):185-93. J Psychiatry Neurosci. 2004. PMID: 15173895 Free PMC article. Review.
-
The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109908. doi: 10.1016/j.pnpbp.2020.109908. Epub 2020 Mar 4. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32145362 Review.
-
The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs.Int J Mol Sci. 2023 Apr 3;24(7):6664. doi: 10.3390/ijms24076664. Int J Mol Sci. 2023. PMID: 37047638 Free PMC article. Review.
Cited by
-
Ketamine-New Possibilities in the Treatment of Depression: A Narrative Review.Life (Basel). 2021 Nov 5;11(11):1186. doi: 10.3390/life11111186. Life (Basel). 2021. PMID: 34833062 Free PMC article. Review.
-
Rehmannia glutinosa DC.-Lilium lancifolium Thunb. in the treatment of depression: a comprehensive review and perspectives.Front Pharmacol. 2024 Oct 30;15:1471307. doi: 10.3389/fphar.2024.1471307. eCollection 2024. Front Pharmacol. 2024. PMID: 39539631 Free PMC article. Review.
-
Advancing Models of Care in Transplant Psychiatry: A Review and Considerations for Enhancing the Multidisciplinary Approach.Curr Psychiatry Rep. 2024 Nov;26(11):626-634. doi: 10.1007/s11920-024-01535-y. Epub 2024 Sep 21. Curr Psychiatry Rep. 2024. PMID: 39305360 Review.
-
Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?Front Cell Neurosci. 2022 Jun 22;16:915587. doi: 10.3389/fncel.2022.915587. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35813508 Free PMC article. Review.
-
Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals.Brain Sci. 2023 Aug 30;13(9):1262. doi: 10.3390/brainsci13091262. Brain Sci. 2023. PMID: 37759862 Free PMC article. Review.
References
-
- Amanatkar HR, Chibnall JT, Seo B-W, Manepalli JN, & Grossberg GT (2014). Impact of exogenous testosterone on mood: A systematic review and meta-analysis of randomized placebo-controlled trials. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists, 26(1), 19–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources